People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arvinas, Inc. | — | Biotechnology | Series C | $129.1M | $1.3B | 2015 |
| Arvinas, Inc. | — | Pharmaceuticals | Seed | $3.5M | $133.6M | 2013 |
| PhytoCeutica, Inc. | — | Pharmaceuticals | Seed | $2.0M | $76.1M | 2010 |
Jonathan Soderstrom at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Soderstrom on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kush Parmar | 2 | 10 |
| Tim Shannon | 2 | 9 |
| ANDREW LEVIN | 1 | 17 |
| Stephen Squinto | 1 | 8 |
| Sean Cassidy | 1 | 7 |
| Craig Crews | 1 | 6 |
| Liam Ratcliffe | 1 | 4 |
| Liam D. Ratcliffe | 1 | 2 |
| John G. Houston | 1 | 2 |
| Brad Margus | 1 | 2 |
| Ian G. Taylor | 1 | 1 |
| Andrew D. Levin | 1 | 1 |
| Sean D. Cassidy | 1 | 1 |
| Tim D. Shannon | 1 | 1 |
| Kush D. Parmar | 1 | 1 |
| Jakob D. Loven | 1 | 1 |
| Stephen D. Squinto | 1 | 1 |
| John D. Houston | 1 | 1 |
| Jonathan D. Soderstrom | 1 | 1 |
| Brad D. Margus | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.